US IPO legal advisers
Q2 2026 · US-listed IPOs · 32 deals · US$99bn disclosed
| 1 | Davis Polk US$84bn · 34.4% share · new | 83,772.0 | 34.4% | New | |
| |||||
| 2 | Latham & Watkins US$84bn · 25.0% share · new | 83,982.7 | 25.0% | New | |
| |||||
| 3 | Vinson & Elkins US$2.6bn · 12.5% share · new | 2,610.1 | 12.5% | New | |
| |||||
| 4 | Sullivan & Cromwell US$7.7bn · 9.4% share · new | 7,653.7 | 9.4% | New | |
| |||||
| 4 | Simpson Thacher & Bartlett US$7.2bn · 9.4% share · new | 7,187.0 | 9.4% | New | |
| |||||
| 4 | Goodwin US$1.4bn · 9.4% share · new | 1,370.0 | 9.4% | New | |
| |||||
| 4 | Celine and Partners US$273m · 9.4% share · new | 272.5 | 9.4% | New | |
| |||||
| 4 | O'Melveny & Myers US$273m · 9.4% share · new | 272.5 | 9.4% | New | |
| |||||
| 9 | Freshfields US$75bn · 6.3% share · new | 75,172.5 | 6.3% | New | |
| |||||
| 9 | Sidley Austin US$5.5bn · 6.3% share · new | 5,462.0 | 6.3% | New | |
| |||||
| 9 | Venable US$2.2bn · 6.3% share · new | 2,212.0 | 6.3% | New | |
| |||||
| 9 | Paul Hastings US$1.9bn · 6.3% share · new | 1,870.8 | 6.3% | New | |
| |||||
| 9 | Cooley US$607m · 6.3% share · new | 607.3 | 6.3% | New | |
| |||||
| 14 | Gibson Dunn US$75bn · 3.1% share · new | 75,000.0 | 3.1% | New | |
| |||||
| 14 | Willkie Farr & Gallagher US$75bn · 3.1% share · new | 75,000.0 | 3.1% | New | |
| |||||
| 14 | Brownstein Hyatt Farber Schreck US$5bn · 3.1% share · new | 5,000.0 | 3.1% | New | |
| |||||
| 14 | Skadden, Arps, Slate, Meagher & Flom US$5bn · 3.1% share · new | 5,000.0 | 3.1% | New | |
| |||||
| 14 | Kirkland & Ellis US$2.2bn · 3.1% share · new | 2,232.7 | 3.1% | New | |
| |||||
| 14 | Ropes & Gray US$1.1bn · 3.1% share · new | 1,134.0 | 3.1% | New | |
| |||||
| 14 | Covington & Burling US$670m · 3.1% share · new | 670.0 | 3.1% | New | |
| |||||
| 14 | Paul, Weiss US$462m · 3.1% share · new | 462.0 | 3.1% | New | |
| |||||
| 14 | Morgan Lewis US$220m · 3.1% share · new | 220.0 | 3.1% | New | |
| |||||
| 14 | Reed Smith US$220m · 3.1% share · new | 220.0 | 3.1% | New | |
| |||||
| 14 | Walkers US$220m · 3.1% share · new | 220.0 | 3.1% | New | |
| |||||
| 14 | Baker Botts US$210m · 3.1% share · new | 210.4 | 3.1% | New | |
| |||||
| 14 | Ellenoff Grossman & Schole US$139m · 3.1% share · new | 138.6 | 3.1% | New | |
| |||||
| 14 | Thompson Coburn US$139m · 3.1% share · new | 138.6 | 3.1% | New | |
| |||||
| 14 | Forbes Hare US$121m · 3.1% share · new | 120.8 | 3.1% | New | |
| |||||
| 14 | Rimon Law US$121m · 3.1% share · new | 120.8 | 3.1% | New | |
| |||||
| 14 | Appleby US$100m · 3.1% share · new | 100.0 | 3.1% | New | |
| |||||
| 14 | Greenberg Traurig US$100m · 3.1% share · new | 100.0 | 3.1% | New | |
| |||||
| 14 | Loeb & Loeb US$80m · 3.1% share · new | 80.0 | 3.1% | New | |
| |||||
| 14 | Norton Rose Fulbright US$80m · 3.1% share · new | 80.0 | 3.1% | New | |
| |||||
| 14 | Bennett Jones US$59.8m · 3.1% share · new | 59.8 | 3.1% | New | |
| |||||
| 14 | Dorsey & Whitney US$59.8m · 3.1% share · new | 59.8 | 3.1% | New | |
| |||||
| 14 | Katten Muchin Rosenman US$59.8m · 3.1% share · new | 59.8 | 3.1% | New | |
| |||||
Top ten by number of deals.
This table's top firms in each year.
Q2 2025 rank is the firm's place in the same period a year earlier, under the same filters. Methodology














